Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001454982-09-000003
Filing Date
2009-02-04
Accepted
2009-02-04 18:18:30
Documents
1
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 5  
1 PRIMARY DOCUMENT edgardoc.xml 5 7281
  Complete submission text file 0001454982-09-000003.txt   9140
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AMYLIN PHARMACEUTICALS INC 9360 TOWNE CENTRE DR SAN DIEGO CA 92121
Business Address 8585522200
BRADBURY DANIEL (Reporting) CIK: 0001236397 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-19700 | Film No.: 09569540